Aptamer Group Past Earnings Performance

Past criteria checks 0/6

Aptamer Group's earnings have been declining at an average annual rate of -44.4%, while the Biotechs industry saw earnings growing at 17.7% annually. Revenues have been growing at an average rate of 13.3% per year.

Key information

-44.4%

Earnings growth rate

-31.1%

EPS growth rate

Biotechs Industry Growth11.5%
Revenue growth rate13.3%
Return on equity-352.3%
Net Margin-677.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

We're Hopeful That Aptamer Group (LON:APTA) Will Use Its Cash Wisely

Mar 15
We're Hopeful That Aptamer Group (LON:APTA) Will Use Its Cash Wisely

Revenue & Expenses Breakdown
Beta

How Aptamer Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

AIM:APTA Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231-740
30 Sep 231-740
30 Jun 232-850
31 Mar 233-660
31 Dec 224-460
30 Sep 224-360
30 Jun 224-250
31 Dec 212-230
30 Sep 212-230
30 Jun 211-230
31 Mar 201-110
31 Mar 191010

Quality Earnings: APTA is currently unprofitable.

Growing Profit Margin: APTA is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: APTA is unprofitable, and losses have increased over the past 5 years at a rate of 44.4% per year.

Accelerating Growth: Unable to compare APTA's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: APTA is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-14.4%).


Return on Equity

High ROE: APTA has a negative Return on Equity (-352.31%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.